Last updated 2 months ago
A Study to Investigate Weight Management With LY3549492 Compared With Placebo in Adult Participants With Obesity or Overweight
275 patients around the world
Available in Argentina
Eli Lilly and Company
3Research sites
275Patients around the world
This study is for people with
Obesity
Requirements for the patient
To 75 Years
All Gender
Medical requirements
- Assigned male at birth.Assigned female at birth, who are of non-childbearing potential.Have a BMI ≥27 kilograms per square meter (kg/m²).Have had a stable body weight for the 3 months prior to randomization (<5% body weight gain and/or loss).
- Have Type 2 Diabetes Mellitus.Have a history of acute or chronic pancreatitis.Have renal impairment.Individuals who are of childbearing potential.Have a prior or planned surgical treatment for obesity, except prior liposuction or abdominoplasty, if performed >1 year prior to screening.Have type 1 diabetes mellitus, latent autoimmune diabetes in adults, or history of ketoacidosis or hyperosmolar coma.Have poorly controlled hypertension.Have signs and symptoms of any liver disease other than nonalcoholic fatty liver disease.Have any of the following cardiovascular conditions within 3 months prior to screening: acute myocardial infarction, cerebrovascular accident (stroke), unstable angina, or hospitalization due to congestive heart failure.Have a history of symptomatic gallbladder disease within the past 2 years.Have a lifetime history of suicide attempts.
Sites
Centro de Investigaciones Metabólicas (CINME) S.A. - CABA, Buenos Aires
Centro Médico Viamonte SRL - CABA, Buenos Aires
Centro Médico Maffei - CABA, Buenos Aires
SponsorEli Lilly and Company
Study typeInterventional
Conditions
Obesity
Requirements
To 75 YearsAll Gender
Unique study IDclinicaltrials.gov
NCT06683508
